Saturday, December 05, 2009 9:09:54 PM
We could speculate all we want about the debt holders reasons for selling, if in fact they are the current sellers. The best clue we have, the last 10Q. 1.3 million shares were converted, that's fact, reasons unknown. What would prevent the debt holders from converting another million shares this quarter??? Even with a news release or releases, the S1 would need to be amended, that doesn't mean the S1 is effective. As long as the S1 is not in effect, the debt holders control the trading in our stock.
Until the debt holders are somehow neutralized, run the course of their conversion, or the S1 is effective, you can say, "Houston, we have a problem."
CP
Until the debt holders are somehow neutralized, run the course of their conversion, or the S1 is effective, you can say, "Houston, we have a problem."
CP
Recent CYRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:30:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/10/2025 09:10:52 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2025 07:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 07:33:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 10:18:14 PM
- Cryoport Reports Third Quarter 2025 Financial Results • PR Newswire (US) • 11/04/2025 09:05:00 PM
- Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain • PR Newswire (US) • 10/30/2025 12:30:00 PM
- Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025 • PR Newswire (US) • 10/21/2025 12:00:00 PM
